Research progress in spike mutations of SARS‐CoV‐2 variants and vaccine development
Medicinal Research Reviews · 2023
DOI: 10.1002/med.21941 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medicinal Research Reviews, 2023. Verfasst von Xuemei He und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geri…. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 239 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
The coronavirus disease 2019 (COVID‐19) pandemic can hardly end with the emergence of different variants over time. In the past 2 years, several variants of severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2), such as the Delta and Omicron variants, have emerged with higher transmissibility, immune evasion and drug resistance, leading to higher morbidity and mortality in the population. The prevalent variants of concern (VOCs) share several mutations on the spike that can affect virus characteristics, including transmissibility, antigenicity, and immune evasion. Increasing evidence has demonstrated that the neutralization capacity of sera from COVID‐19 convalescent or vaccinated individuals is decreased against SARS‐CoV‐2 variants. Moreover, the vaccine effectiveness of current COVID‐19 vaccines against SARS‐CoV‐2 VOCs is not as high as that against wild‐type SARS‐CoV‐2. Therefore, more attention might be paid to how the mutations impact vaccine effectiveness. In this review, we summarized the current studies on the mutations of the SARS‐CoV‐2 spike, particularly of the receptor binding domain, to elaborate on how the mutations impact the infectivity, transmissibility and immune evasion of the virus. The effects of mutations in the SARS‐CoV‐2 spike on the current therapeutics were highlighted, and potential strategies for future vaccine development were suggested.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, Chi…
ORCID-Profile: Xiawei Wei
Förderung
- National Natural Science Foundation of China
Zitieren
APA
He, X., He, C., Hong, W., Yang, J., & Wei, X. (2023). Research progress in spike mutations of SARS‐CoV‐2 variants and vaccine development. Medicinal Research Reviews. https://doi.org/10.1002/med.21941
Vancouver
He X, He C, Hong W, Yang J, Wei X. Research progress in spike mutations of SARS‐CoV‐2 variants and vaccine development. Medicinal Research Reviews. 2023. doi:10.1002/med.21941
BibTeX
@article{He2023,
author = {He, Xuemei and He, Cai and Hong, Weiqi and Yang, Jingyun and Wei, Xiawei},
title = {Research progress in spike mutations of SARS‐CoV‐2 variants and vaccine development},
journal = {Medicinal Research Reviews},
year = {2023},
doi = {10.1002/med.21941}
}
EUVIMED